Literature DB >> 24097232

Reconstruction using a frozen tumor-bearing vertebra in total en bloc spondylectomy can enhance antitumor immunity.

Hideki Murakami1, Satoshi Kato, Yasuhiro Ueda, Yoshiyasu Fujimaki, Hiroyuki Tsuchiya.   

Abstract

PURPOSE: Distant metastases from thyroid carcinoma are successfully cured if they take up radioiodine ((131)I), are of small size, and located in the lungs. Bone metastases have the worst prognosis because (131)I therapy and external beam radiotherapy are less effective. Our propose here is to report a patient with solitary spinal metastasis and multiple lung metastases from thyroid carcinoma, whose spinal metastasis was treated by total en bloc spondylectomy (TES) enhancing antitumor immunity using frozen tumor-bearing bone for spinal reconstruction.
METHODS: The patient was a 37-year-old male who had solitary spinal metastasis at T4 and multiple lung metastases from thyroid carcinoma. (131)I therapy for the multiple lung metastases resulted in no effect because the apparent (131)I uptake was observed only in T4 metastasis. We performed a TES of T4 with cryotreatment. After en bloc excision of T4, the excised tumor-bearing vertebra was frozen by liquid nitrogen. In spinal reconstruction, the frozen vertebra was used in a mesh cage inserted into the anterior defect.
RESULTS: After surgery, the thyroglobulin level decreased without any other adjuvant therapy and the serum levels of INF-γ and IL-12 increased. This indicates antitumor immunity was activated. Then, (131)I therapy became effective to the lung metastases causing the tumors to decrease in size and number. Three years after surgery, progression in the lung metastases, other metastasis, and local recurrence have not been observed.
CONCLUSIONS: TES with cryotreatment as presented is a novel surgery which can enhance antitumor immunity against other visible or non-visible metastases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24097232     DOI: 10.1007/s00586-013-3056-2

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  21 in total

Review 1.  Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; R T Kloos
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

Review 3.  Approach to and treatment of differentiated thyroid carcinoma.

Authors:  Furio Pacini; Maria Grazia Castagna
Journal:  Med Clin North Am       Date:  2012-02-10       Impact factor: 5.456

4.  Cryotreatment against metastatic renal cell bone tumour reduced multiple lung metastases.

Authors:  Hideji Nishida; Toshiharu Shirai; Katsuhiro Hayashi; Akihiko Takeuchi; Yoshikazu Tanzawa; Atsushi Mizokami; Mikio Namiki; Hiroyuki Tsuchiya
Journal:  Anticancer Res       Date:  2011-09       Impact factor: 2.480

5.  Immunologic response to cryoablation of breast cancer.

Authors:  Michael S Sabel; Matthew A Nehs; Gang Su; Kathleen P Lowler; James L M Ferrara; Alfred E Chang
Journal:  Breast Cancer Res Treat       Date:  2005-03       Impact factor: 4.872

6.  In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study.

Authors:  J J Joosten; G N Muijen; T Wobbes; T J Ruers
Journal:  Cryobiology       Date:  2001-02       Impact factor: 2.487

7.  Total en bloc spondylectomy for spinal tumors: improvement of the technique and its associated basic background.

Authors:  Katsuro Tomita; Norio Kawahara; Hideki Murakami; Satoru Demura
Journal:  J Orthop Sci       Date:  2006-01       Impact factor: 1.601

8.  Antitumor effects of residual tumor after cryoablation: the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model.

Authors:  Masato Urano; Chihiro Tanaka; Yasuyuki Sugiyama; Kiichi Miya; Shigetoyo Saji
Journal:  Cryobiology       Date:  2003-06       Impact factor: 2.487

Review 9.  Evaluation and treatment of spinal metastases: an overview.

Authors:  W B Jacobs; R G Perrin
Journal:  Neurosurg Focus       Date:  2001-12-15       Impact factor: 4.047

10.  Re-implantation of tumour tissue treated by cryotreatment with liquid nitrogen induces anti-tumour activity against murine osteosarcoma.

Authors:  H Nishida; H Tsuchiya; K Tomita
Journal:  J Bone Joint Surg Br       Date:  2008-09
View more
  5 in total

1.  Total en bloc spondylectomy.

Authors:  Morgan Jones; James Holton; Simon Hughes; Marcin Czyz
Journal:  J Spine Surg       Date:  2018-09

2.  Disappearance of lung adenocarcinoma after total en bloc spondylectomy using frozen tumor-bearing vertebra for reconstruction.

Authors:  Shurei Sugita; Hideki Murakami; Satoshi Kato; Sakae Tanaka; Hiroyuki Tsuchiya
Journal:  Eur Spine J       Date:  2015-06-23       Impact factor: 3.134

3.  Lung metastases regression with increased CD8+ T lymphocyte infiltration following preoperative spinal embolization and total en bloc spondylectomy using tumor-bearing frozen autograft in a patient with spinal metastatic leiomyosarcoma.

Authors:  Noritaka Yonezawa; Hideki Murakami; Apiruk Sangsin; Eishiro Mizukoshi; Hiroyuki Tsuchiya
Journal:  Eur Spine J       Date:  2018-11-21       Impact factor: 3.134

4.  Total en bloc spondylectomy for locally aggressive and primary malignant tumors of the lumbar spine.

Authors:  Daniel M Sciubba; Rafael De la Garza Ramos; C Rory Goodwin; Risheng Xu; Ali Bydon; Timothy F Witham; Ziya L Gokaslan; Jean-Paul Wolinsky
Journal:  Eur Spine J       Date:  2016-06-04       Impact factor: 3.134

5.  Abscopal Effect of Frozen Autograft Reconstruction Combined with an Immune Checkpoint Inhibitor Analyzed Using a Metastatic Bone Tumor Model.

Authors:  Noritaka Yonezawa; Hideki Murakami; Satoru Demura; Satoshi Kato; Shinji Miwa; Katsuhito Yoshioka; Kazuya Shinmura; Noriaki Yokogawa; Takaki Shimizu; Norihiro Oku; Ryo Kitagawa; Makoto Handa; Ryohei Annen; Yuki Kurokawa; Kazumi Fushimi; Eishiro Mizukoshi; Hiroyuki Tsuchiya
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.